Skip to main content

Advertisement

Figure 2 | BMC Medicine

Figure 2

From: Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa

Figure 2

Infections averted over 20 years with portfolios of scaled-up ART and PrEP. (A) Infections averted over 20 years with portfolios of scaled-up Guidelines ART (individuals with CD4 cell counts ≤ 350 cells/μL only) and General PrEP (general population). (B) Infections averted over 20 years with portfolios of scaled up Universal ART (all HIV-infected individuals) and General PrEP (general population).

Back to article page